Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,255,383
+$124,937 QoQ
Shares Held
33,682
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#618
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. GILD ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,255,383 | 33,682 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $4,130,446 | 33,652 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,707,622 | 33,402 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,815,812 | 34,417 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,029,047 | 27,033 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,055,327 | 11,425 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $997,779 | 11,901 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $782,840 | 11,410 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $920,239 | 12,563 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,110,242 | 13,705 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,006,369 | 13,429 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,037,208 | 13,458 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,095,286 | 13,201 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,158,631 | 13,496 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $683,031 | 11,072 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $625,579 | 10,121 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $502,293 | 8,449 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $595,547 | 8,202 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $568,090 | 8,133 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $534,284 | 7,759 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $981,858 | 15,192 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $401,469 | 6,891 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $422,361 | 6,684 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $703,385 | 9,142 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,132,730 | 15,152 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||